Abstract

Objectives. To retrospectively compare the results of the MRIA (magnetic resonance index of activity) with a modified MRIA (mMRIA), which was calculated excluding from MRIA formula the data of relative contrast enhancement (RCE). Materials and Methods. MR-E and corresponding endoscopic records of 100 patients were reviewed. MRIA, mMRIA, and SES endoscopic index were calculated for all the patients. Namely, MRIA was calculated as follows: (1.5 × wall thickening + 0.02 × RCE + 5 × intramural edema + 10 × ulcers), while mMRIA was calculated with the modified formula (1.5 × wall thickening + 5 × intramural edema + 10 × ulcers). Results. Mean MRIA and mMRIA values were 19.3 and 17.68, respectively (p < 0.0001). A significant correlation (p < 0.0001) was observed between MRIA and mMRIA scores and between both MR indexes and SES (p < 0.0001). Conclusions. mMRIA was comparable to MRIA in the evaluation of disease activity in Crohn's disease.

Highlights

  • Crohn’s disease (CD) is a chronic progressive inflammatory disorder of the entire alimentary tract, classically involving the terminal ileum: ileitis is observed in 90% of the patients with small-intestinal CD, who in turn constitute 30–40% of all CD patients [1].The disease is characterized by a relapsing and remitting course, posing the problem of repeated follow-ups over time for the assessment of disease activity.To assess the severity of clinical disease activity, composite scores such as Crohn’s Disease Activity Index (CDAI) or the Harvey-Bradshaw Index are used [2].Ileocolonoscopy has been recognized as the gold standard for the evaluation of lesions in the colon and terminal ileum

  • To retrospectively compare the results of the MR index of activity (MRIA) with a modified MRIA, which was calculated excluding from MRIA formula the data of relative contrast enhancement (RCE)

  • Number of patients 3 27 51 19 remission was diagnosed in 3/100 patients (3%), a mild disease activity in 27/100 (27%) cases, a moderate activity (7–15) in 51/100 (51%) patients, and a severe disease (>15) in the remaining 19/100 (19%) patients (Table 3). Both the readers demonstrated the involvement of the terminal ileum in 75/100 patients, while the terminal ileum was considered normal in 25/100 cases

Read more

Summary

Introduction

Crohn’s disease (CD) is a chronic progressive inflammatory disorder of the entire alimentary tract, classically involving the terminal ileum: ileitis is observed in 90% of the patients with small-intestinal CD, who in turn constitute 30–40% of all CD patients [1].The disease is characterized by a relapsing and remitting course (flare-ups followed by clinical remission), posing the problem of repeated follow-ups over time for the assessment of disease activity.To assess the severity of clinical disease activity, composite scores such as Crohn’s Disease Activity Index (CDAI) or the Harvey-Bradshaw Index are used [2].Ileocolonoscopy has been recognized as the gold standard for the evaluation of lesions in the colon and terminal ileum. Crohn’s disease (CD) is a chronic progressive inflammatory disorder of the entire alimentary tract, classically involving the terminal ileum: ileitis is observed in 90% of the patients with small-intestinal CD, who in turn constitute 30–40% of all CD patients [1]. To assess the severity of clinical disease activity, composite scores such as Crohn’s Disease Activity Index (CDAI) or the Harvey-Bradshaw Index are used [2]. Plays a vital role in diagnosing and phenotyping CD, thereafter assessing disease activity and complications [4]. MR enterography (MR-E) of the small bowel, thanks to the lack of ionizing radiation, along with very high soft-tissue contrast and multiplanar images has high diagnostic accuracy in the evaluation of luminal and extraluminal abnormalities [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call